Rchr
J-GLOBAL ID:200901075118689095   Update date: Apr. 07, 2021

Tsujita Kenichi

Tsujita Kenichi
Affiliation and department:
Job title: 教授
Other affiliations (2):
  • 熊本大学病院  副病院長
  • Kumamoto University Hospital Cardiovascular Center  Director
Research field  (1): Cardiology
Research keywords  (6): Coronary Atherosclerosis ,  Coronary Microvascular Circulation ,  Acute Myocardial Infarction ,  Coronary Imaging ,  再潅流傷害 ,  Reperfusion Injury
Research theme for competitive and other funds  (9):
  • 2020 - 2025 心臓CTを用いた心筋組織性状評価:心アミロイドーシス診断ストラテジーの確立
  • 2020 - 2025 ドミノ肝移植レシピエントの心機能評価を利用した心アミロイドーシス早期診断法の開発
  • 2018 - 2021 非虚血性心不全における冠微小循環障害のメカニズム解明と治療戦略開発
  • 2017 - 2019 Development of prevention/treatment system of diabetes targeting the DsbA-L gene
  • 2014 - 2017 Impact of Culprit Plaque Tissue and Microvascular Embolization on Reperfusion Injury and Development of Optimal Interventional Procedures
Show all
Papers (403):
  • Taiki Nishihara, Eiichiro Yamamoto, Daisuke Sueta, Koichiro Fujisue, Hiroki Usuku, Fumi Oike, Masafumi Takae, Noriaki Tabata, Miwa Ito, Kenshi Yamanaga, et al. Impact of Reactive Oxidative Metabolites Among New Categories of Nonischemic Heart Failure. Journal of the American Heart Association. 2021. 10. 7. e016765
  • Koichi Kaikita, Kenichi Tsujita. Inhibitory Effect of Rivaroxaban on Atrial Arrhythmogenesis via Protease-Activated Receptor 2 Pathway. Circulation journal : official journal of the Japanese Circulation Society. 2021
  • Satoshi Kitahara, Yu Kataoka, Hiroyuki Miura, Tatsuya Nishii, Kunihiro Nishimura, Kota Murai, Takamasa Iwai, Hayato Nakamura, Hayato Hosoda, Hideo Matama, et al. The feasibility and limitation of coronary computed tomographic angiography imaging to identify coronary lipid-rich atheroma in vivo: Findings from near-infrared spectroscopy analysis. Atherosclerosis. 2021. 322. 1-7
  • Taishi Nakamura, Kenichi Tsujita. Current trends and future perspectives for heart failure treatment leveraging cGMP modifiers and the practical effector PKG. Journal of cardiology. 2021
  • Tadashi Hoshiyama, Keiichi Ashikaga, Kenichi Tsujita, Yoshisato Shibata. Efficacy of cryo-ablation during atrioventricular nodal reentrant tachycardia. Heart and Vessels. 2021. 36. 4. 541-548
more...
MISC (340):
  • Kenji Sadamatsu, Masaaki Okutsu, Satoru Sumitsuji, Tomohiro Kawasaki, Sunao Nakamura, Yoshihiro Fukumoto, Kenichi Tsujita, Shinjo Sonoda, Yoshio Kobayashi, Yuji Ikari. Practical utilization of cardiac computed tomography for the success in complex coronary intervention. Cardiovascular Intervention and Therapeutics. 2021. 36. 2. 178-189
  • 掃本 誠治, 辻田 賢一, 小川 久雄. 災害時の循環器疾患管理 経験とエビデンスに基づく提言(第3回)(最終回) 熊本大地震の経験と提言. Heart View. 2021. 25. 3. 296-301
  • 山本 英一郎, 辻田 賢一. 【治療抵抗性高血圧への対処-腎デナベーションを含めて】治療抵抗性高血圧への代替療法としての腎デナベーション. カレントテラピー. 2021. 39. 1. 80-85
  • Kazumasa Kurogi, Masanobu Ishii, Nobuyasu Yamamoto, Kenshi Yamanaga, Kenichi Tsujita. Optical coherence tomography-guided percutaneous coronary intervention: a review of current clinical applications. Cardiovascular Intervention and Therapeutics. 2021. 36. 2. 169-177
  • Daisuke Sueta, Koichi Kaikita, Kenichi Matsushita, Kenichi Tsujita. eThrombosis: A new risk factor for venous thromboembolism in the pandemic era. Research and Practice in Thrombosis and Haemostasis. 2021. 5. 1. 243-244
more...
Education (3):
  • 2007 - 2009 Columbia University Medical Center
  • 1992 - 1998 Kumamoto University School of Medicine
  • 1992 - 1998 Kumamoto University School of Medicine
Association Membership(s) (15):
日本心臓核医学会 ,  日本心血管画像動態学会 ,  日本冠疾患学会 ,  JAPANESE HEART FAILURE SOCIETY ,  JAPANESE COLLEGE OF CARDIOLOGY ,  JAPANESE ASSOCIATION OF CARDIOVASCULAR INTERVENTION AND THERAPEUTICS ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE ,  日本循環器学会 ,  日本成人先天性心疾患学会 ,  日本高血圧学会 ,  The Japanese Onco-Cardiology Society ,  Japan Transcatheter Valve Therapies ,  Japan Atherosclerosis Society ,  The Japanese Association of Cardiac Rehabilitation ,  Japanese Heart Rhythm Society
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page